|| OncoTarget || Aging ||

Impact Journals News

Impact Journals LLC presents OncoTarget, a High-Impact Journal for the 21st century.

ONCOTARGET is coming March 2010.

OncoTarget publishes papers of outstanding significance, exceptional novelty, and ground-breaking discoveries in all disciplines, from basic research to clinical applications.

Revolutionary publishing allows us to publish overnight, on open access, and free for the authors of Priority Research Papers and Special Articles (Research Perspectives, Previews, Biotechnology and Patent Reviews, Special Reviews).

Mission

Rapid and constructive peer-review, with overnight publication of scientific discoveries, ground-breaking insights, and ideas to facilitate the applications of basic research to therapy.

Oncotarget - Editorial Board

Editors-in-Chief

• Mikhail V. Blagosklonny
  Roswell Park Cancer Institute, Buffalo, NY
• Andrei V. Gudkov
  Roswell Park Cancer Institute, Buffalo, NY

---

Founding Editorial Board

• Frederick Alt
  Harvard Medical School, Boston, MA
• Carlo M. Croce
  The Ohio State University,Columbus, OH
• Ronald A. DePinho
  Dana-Farber Cancer Institute, Boston, MA
• Brian J. Druker
  Oregon Health Science University, Portland, OR
• Arnold Levine
  Institute for Advanced Study, Princeton, NJ
• Arthur B. Pardee
  Harvard University, Boston, MA
• Gregg L. Semenza
  Johns Hopkins University, Baltimore, MD
• Alexander Varshavsky
  California Institute of Technology, Pasadena, CA
• Bert Vogelstein
  Johns Hopkins University, Baltimore, MD

Call for Papers

Inaugural Issues - all papers are Free for the authors and on Open access.

Please submit your paper or presubmission inquiry to: editors@oncotarget.com